Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Analgesia, Epidural | 12 | 2022 | 50 | 4.570 |
Why?
|
Analgesia, Obstetrical | 13 | 2022 | 47 | 4.440 |
Why?
|
Fever | 6 | 2019 | 56 | 2.060 |
Why?
|
Labor, Obstetric | 7 | 2022 | 31 | 1.970 |
Why?
|
Pregnancy | 25 | 2022 | 807 | 1.470 |
Why?
|
Drug Contamination | 2 | 2018 | 5 | 1.360 |
Why?
|
Intubation, Intratracheal | 3 | 2021 | 70 | 1.180 |
Why?
|
Internship and Residency | 5 | 2014 | 283 | 1.030 |
Why?
|
Anesthetics | 2 | 2018 | 19 | 1.030 |
Why?
|
Anesthesia, Obstetrical | 4 | 2015 | 22 | 1.020 |
Why?
|
Face | 2 | 2014 | 25 | 0.870 |
Why?
|
Post-Dural Puncture Headache | 1 | 2022 | 3 | 0.860 |
Why?
|
Anesthesiology | 3 | 2014 | 49 | 0.810 |
Why?
|
Pregnancy Complications | 3 | 2020 | 78 | 0.780 |
Why?
|
Plagiarism | 2 | 2010 | 4 | 0.780 |
Why?
|
School Admission Criteria | 2 | 2010 | 11 | 0.760 |
Why?
|
Infection Control | 1 | 2019 | 21 | 0.730 |
Why?
|
Female | 34 | 2023 | 18112 | 0.730 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 55 | 0.710 |
Why?
|
Operating Rooms | 2 | 2018 | 32 | 0.690 |
Why?
|
Inflammation Mediators | 2 | 2017 | 101 | 0.690 |
Why?
|
Syringes | 1 | 2018 | 5 | 0.680 |
Why?
|
Equipment Contamination | 1 | 2018 | 11 | 0.680 |
Why?
|
Bacteria | 1 | 2018 | 45 | 0.660 |
Why?
|
Humans | 36 | 2023 | 28998 | 0.650 |
Why?
|
Fetus | 2 | 2019 | 78 | 0.650 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 161 | 0.640 |
Why?
|
Cesarean Section | 5 | 2013 | 82 | 0.590 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 325 | 0.570 |
Why?
|
Uterus | 2 | 2008 | 73 | 0.520 |
Why?
|
Perinatology | 1 | 2014 | 2 | 0.500 |
Why?
|
Pattern Recognition, Visual | 1 | 2014 | 12 | 0.490 |
Why?
|
Labor Pain | 1 | 2013 | 8 | 0.470 |
Why?
|
Obstetric Labor Complications | 1 | 2013 | 12 | 0.470 |
Why?
|
Societies, Medical | 1 | 2014 | 149 | 0.460 |
Why?
|
Anesthetics, Local | 2 | 2003 | 77 | 0.430 |
Why?
|
Delivery, Obstetric | 4 | 2017 | 49 | 0.420 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 11 | 0.400 |
Why?
|
Pregnancy, Animal | 2 | 2019 | 19 | 0.390 |
Why?
|
Body Temperature Regulation | 1 | 2010 | 19 | 0.390 |
Why?
|
Postoperative Complications | 2 | 2014 | 670 | 0.390 |
Why?
|
Brain | 1 | 2017 | 928 | 0.380 |
Why?
|
Time Factors | 5 | 2019 | 1997 | 0.370 |
Why?
|
Epidural Space | 1 | 2009 | 7 | 0.370 |
Why?
|
Cohort Studies | 5 | 2023 | 1674 | 0.360 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 45 | 0.360 |
Why?
|
Medical Errors | 1 | 2009 | 36 | 0.350 |
Why?
|
Physicians | 1 | 2021 | 134 | 0.340 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 241 | 0.340 |
Why?
|
Catecholamines | 1 | 2008 | 17 | 0.320 |
Why?
|
Vasoconstriction | 1 | 2008 | 40 | 0.320 |
Why?
|
Vasodilator Agents | 1 | 2008 | 54 | 0.320 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2007 | 4 | 0.310 |
Why?
|
Scopolamine | 1 | 2007 | 6 | 0.310 |
Why?
|
Antiemetics | 1 | 2007 | 5 | 0.310 |
Why?
|
Ondansetron | 1 | 2007 | 5 | 0.310 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 62 | 0.310 |
Why?
|
Vasodilation | 1 | 2008 | 87 | 0.310 |
Why?
|
Inhibin-beta Subunits | 1 | 2007 | 2 | 0.310 |
Why?
|
Placenta Diseases | 1 | 2007 | 4 | 0.310 |
Why?
|
Morphine | 1 | 2007 | 57 | 0.300 |
Why?
|
Arterioles | 2 | 2008 | 12 | 0.300 |
Why?
|
Spinal Puncture | 2 | 2008 | 20 | 0.300 |
Why?
|
Clinical Competence | 1 | 2009 | 307 | 0.300 |
Why?
|
Bupivacaine | 2 | 2003 | 48 | 0.280 |
Why?
|
Rats, Sprague-Dawley | 4 | 2017 | 747 | 0.280 |
Why?
|
Rats | 5 | 2019 | 1604 | 0.270 |
Why?
|
Reproducibility of Results | 3 | 2019 | 724 | 0.270 |
Why?
|
Analgesics, Opioid | 2 | 2008 | 236 | 0.270 |
Why?
|
United States | 4 | 2023 | 3604 | 0.260 |
Why?
|
Adult | 12 | 2021 | 8391 | 0.250 |
Why?
|
Academic Medical Centers | 2 | 2023 | 150 | 0.240 |
Why?
|
Electronics | 1 | 2023 | 14 | 0.240 |
Why?
|
Observer Variation | 3 | 2014 | 96 | 0.230 |
Why?
|
Dystocia | 1 | 2003 | 2 | 0.230 |
Why?
|
Receptors, Adrenergic | 1 | 2002 | 7 | 0.220 |
Why?
|
Meningitis | 1 | 2002 | 9 | 0.220 |
Why?
|
Laryngoscopy | 2 | 2014 | 39 | 0.220 |
Why?
|
Punctures | 1 | 2022 | 32 | 0.210 |
Why?
|
Medicare | 1 | 2023 | 185 | 0.210 |
Why?
|
Needles | 1 | 2002 | 28 | 0.210 |
Why?
|
Monitoring, Intraoperative | 2 | 2012 | 39 | 0.210 |
Why?
|
Male | 12 | 2021 | 17767 | 0.210 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 52 | 0.200 |
Why?
|
Foreign Medical Graduates | 2 | 2010 | 2 | 0.200 |
Why?
|
Animals | 6 | 2019 | 7296 | 0.180 |
Why?
|
Weights and Measures | 1 | 2019 | 3 | 0.180 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 87 | 0.180 |
Why?
|
Video Recording | 1 | 2019 | 51 | 0.180 |
Why?
|
Dentate Gyrus | 1 | 2019 | 6 | 0.180 |
Why?
|
Maternal Exposure | 1 | 2019 | 10 | 0.180 |
Why?
|
Drug Packaging | 1 | 2018 | 4 | 0.170 |
Why?
|
Microglia | 1 | 2019 | 48 | 0.170 |
Why?
|
Infant, Newborn | 3 | 2020 | 595 | 0.170 |
Why?
|
Interleukin-6 | 1 | 2019 | 224 | 0.160 |
Why?
|
Retrospective Studies | 7 | 2020 | 3100 | 0.160 |
Why?
|
Magnesium | 1 | 2017 | 22 | 0.160 |
Why?
|
Prevalence | 2 | 2010 | 892 | 0.160 |
Why?
|
Inflammation | 2 | 2019 | 503 | 0.160 |
Why?
|
Body Mass Index | 1 | 2020 | 862 | 0.150 |
Why?
|
Dexmedetomidine | 1 | 2016 | 8 | 0.140 |
Why?
|
Somatosensory Cortex | 1 | 2016 | 26 | 0.140 |
Why?
|
Ketamine | 1 | 2016 | 20 | 0.140 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 2 | 0.140 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 373 | 0.140 |
Why?
|
Thrombocytopenia | 1 | 2015 | 32 | 0.140 |
Why?
|
Aged | 5 | 2023 | 9461 | 0.130 |
Why?
|
Incidence | 3 | 2020 | 1105 | 0.130 |
Why?
|
Analgesics | 1 | 2016 | 125 | 0.130 |
Why?
|
Risk Factors | 2 | 2013 | 3509 | 0.120 |
Why?
|
Apoptosis | 1 | 2016 | 337 | 0.120 |
Why?
|
Capillaries | 1 | 2012 | 23 | 0.110 |
Why?
|
Body Weight | 1 | 2014 | 290 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 33 | 0.100 |
Why?
|
Arteries | 1 | 2012 | 60 | 0.100 |
Why?
|
Mitral Valve Stenosis | 1 | 2011 | 8 | 0.100 |
Why?
|
Mitral Valve | 1 | 2011 | 28 | 0.100 |
Why?
|
Echocardiography | 1 | 2011 | 140 | 0.100 |
Why?
|
Ethics, Professional | 1 | 2010 | 6 | 0.100 |
Why?
|
Therapy, Computer-Assisted | 1 | 2010 | 2 | 0.100 |
Why?
|
Blood Glucose | 2 | 2012 | 465 | 0.100 |
Why?
|
Anesthesia, Epidural | 2 | 2008 | 23 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 284 | 0.100 |
Why?
|
Algorithms | 1 | 2014 | 461 | 0.100 |
Why?
|
Canada | 1 | 2010 | 48 | 0.100 |
Why?
|
Medicine | 1 | 2010 | 30 | 0.090 |
Why?
|
Air | 1 | 2009 | 6 | 0.090 |
Why?
|
Sodium Chloride | 1 | 2009 | 24 | 0.090 |
Why?
|
Data Collection | 1 | 2010 | 163 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2008 | 501 | 0.090 |
Why?
|
Puerperal Infection | 1 | 2009 | 3 | 0.090 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2009 | 6 | 0.090 |
Why?
|
Postpartum Hemorrhage | 1 | 2009 | 14 | 0.090 |
Why?
|
Internet | 1 | 2010 | 156 | 0.090 |
Why?
|
Perioperative Care | 1 | 2009 | 58 | 0.090 |
Why?
|
Anesthesia, Conduction | 1 | 2009 | 29 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 207 | 0.090 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 27 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 39 | 0.090 |
Why?
|
Religion | 1 | 2008 | 30 | 0.090 |
Why?
|
Pericardium | 1 | 2009 | 50 | 0.080 |
Why?
|
Aortic Valve | 1 | 2009 | 47 | 0.080 |
Why?
|
Analgesia | 1 | 2008 | 33 | 0.080 |
Why?
|
Sex Factors | 1 | 2010 | 626 | 0.080 |
Why?
|
Terbutaline | 1 | 2008 | 1 | 0.080 |
Why?
|
Gravidity | 1 | 2008 | 2 | 0.080 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2008 | 5 | 0.080 |
Why?
|
Prazosin | 1 | 2008 | 9 | 0.080 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2008 | 27 | 0.080 |
Why?
|
Propranolol | 1 | 2008 | 16 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2009 | 71 | 0.080 |
Why?
|
Regional Blood Flow | 1 | 2008 | 82 | 0.080 |
Why?
|
Epinephrine | 1 | 2008 | 41 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 59 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 1 | 2008 | 50 | 0.080 |
Why?
|
Norepinephrine | 1 | 2008 | 73 | 0.080 |
Why?
|
Injections, Intravenous | 1 | 2007 | 73 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2009 | 708 | 0.080 |
Why?
|
Injections, Spinal | 1 | 2007 | 124 | 0.080 |
Why?
|
Administration, Cutaneous | 1 | 2007 | 107 | 0.080 |
Why?
|
Middle Aged | 6 | 2021 | 10805 | 0.080 |
Why?
|
Age Factors | 1 | 2010 | 1105 | 0.070 |
Why?
|
Risk Assessment | 2 | 2010 | 1300 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 641 | 0.070 |
Why?
|
Herbal Medicine | 2 | 2002 | 7 | 0.070 |
Why?
|
Oxytocics | 1 | 2003 | 11 | 0.060 |
Why?
|
Amides | 1 | 2003 | 20 | 0.060 |
Why?
|
Oxytocin | 1 | 2003 | 22 | 0.060 |
Why?
|
Phytotherapy | 1 | 2002 | 38 | 0.060 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2002 | 2 | 0.050 |
Why?
|
Acyl-CoA Dehydrogenases | 1 | 2002 | 2 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2002 | 8 | 0.050 |
Why?
|
Atenolol | 1 | 2002 | 6 | 0.050 |
Why?
|
Nerve Block | 1 | 2003 | 48 | 0.050 |
Why?
|
Isoproterenol | 1 | 2002 | 18 | 0.050 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2002 | 13 | 0.050 |
Why?
|
Phenylephrine | 1 | 2002 | 27 | 0.050 |
Why?
|
Cerebrospinal Fluid | 1 | 2002 | 13 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2002 | 32 | 0.050 |
Why?
|
Cardiology | 1 | 2002 | 71 | 0.050 |
Why?
|
Equipment Design | 1 | 2002 | 167 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2002 | 113 | 0.050 |
Why?
|
Pain Measurement | 1 | 2003 | 360 | 0.050 |
Why?
|
Maternal Age | 1 | 2020 | 8 | 0.050 |
Why?
|
Logistic Models | 1 | 2003 | 725 | 0.050 |
Why?
|
Birth Weight | 1 | 2020 | 38 | 0.050 |
Why?
|
Gestational Age | 1 | 2020 | 95 | 0.050 |
Why?
|
Treatment Outcome | 1 | 2007 | 3094 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2019 | 37 | 0.040 |
Why?
|
Temperature | 1 | 2019 | 55 | 0.040 |
Why?
|
Mothers | 1 | 2019 | 79 | 0.040 |
Why?
|
Brain Injuries | 1 | 2019 | 94 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 784 | 0.040 |
Why?
|
Infant | 1 | 2020 | 967 | 0.040 |
Why?
|
Calcium | 1 | 2019 | 296 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 871 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 1164 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2019 | 573 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 118 | 0.040 |
Why?
|
Cell Death | 1 | 2016 | 71 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 21 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2016 | 111 | 0.030 |
Why?
|
Random Allocation | 1 | 2016 | 212 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2020 | 2105 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2016 | 454 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1353 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2012 | 3712 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2012 | 41 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2011 | 57 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2012 | 82 | 0.030 |
Why?
|
Linear Models | 1 | 2012 | 425 | 0.020 |
Why?
|
Reoperation | 1 | 2011 | 203 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 531 | 0.020 |
Why?
|
Mepivacaine | 1 | 2008 | 2 | 0.020 |
Why?
|
Sufentanil | 1 | 2008 | 5 | 0.020 |
Why?
|
Labor Stage, First | 1 | 2008 | 6 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2009 | 48 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 40 | 0.020 |
Why?
|
Fentanyl | 1 | 2008 | 33 | 0.020 |
Why?
|
Anesthesia, Spinal | 1 | 2008 | 21 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2009 | 262 | 0.020 |
Why?
|
Blood Pressure | 1 | 2011 | 803 | 0.020 |
Why?
|
Prospective Studies | 1 | 2012 | 2010 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 2398 | 0.020 |
Why?
|
Adolescent | 1 | 2012 | 3248 | 0.020 |
Why?
|
Plants, Medicinal | 1 | 2002 | 9 | 0.010 |
Why?
|
Labor, Induced | 1 | 2002 | 10 | 0.010 |
Why?
|
Preoperative Care | 1 | 2002 | 110 | 0.010 |
Why?
|
Electrocardiography | 1 | 2002 | 562 | 0.010 |
Why?
|